Literature DB >> 11506111

Local administration of morphine for analgesia after iliac bone graft harvest.

S S Reuben1, P Vieira, S Faruqi, A Verghis, P A Kilaru, H Maciolek.   

Abstract

BACKGROUND: Harvesting autogenous bone grafts from the ilium may cause considerable pain and may represent a significant source of postoperative morbidity. The local application of morphine can reduce pain in a rat model of bone damage. We evaluated the analgesic efficacy of administering morphine to the donor bone graft site for spinal fusionsurgery.
METHODS: Sixty patients undergoing cervical spinal fusion surgery using autogenous bone harvested from the ilium were randomly assigned to one of three groups: Group 1 was given saline infiltrated into the harvest site, group 2 was given 5 mg intramuscular morphine; group 3 was given 5 mg morphine infiltrated into the harvest site. After surgery, all patients were given morphine through a patient-controlled analgesia pump. Pain scores both from the harvest and the incision sites, as well as morphine use, were recorded at 2, 4, 6, 8, 12, and 24 h after surgery. At 1 yr after surgery the presence and subjective characteristics of donor site pain were recorded.
RESULTS: Total 24-h morphine use (milligrams) was significantly lower (P < 0.0001) in group 3 (33.7+/-8.3 mg, mean +/- SD), compared with either group 1 (64.3+/-6.6 mg) or group 2 (59.6+/-9.3 mg). Pain from the graft site was scored the same at 2 h but remained significantly lower (P < 0.0001) for group 3 at all later time intervals. Pain scores from the incision site were similar among the three study groups. One year after surgery, 25% of patients reported having chronic donor site pain. The association of chronic donor site pain was significantly higher (P < 0.05) in groups 1 (33%) and 2 (37%) compared with group 3 (5%).
CONCLUSION: Low-dose morphine applied to the harvest graft site can reduce local pain, morphine use, and chronic donor site pain after cervical spine fusion surgery.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11506111     DOI: 10.1097/00000542-200108000-00021

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  15 in total

Review 1.  Peripheral opioid analgesia: clinical applications.

Authors:  Jochen Oeltjenbruns; Michael Schäfer
Journal:  Curr Pain Headache Rep       Date:  2005-02

Review 2.  [Potential applications and significance of peripheral opioid analgesia].

Authors:  J Oeltjenbruns; M Schäfer
Journal:  Schmerz       Date:  2005-10       Impact factor: 1.107

3.  [Pain therapy after spinal surgery].

Authors:  F Geiger; P Kessler; M Rauschmann
Journal:  Orthopade       Date:  2008-10       Impact factor: 1.087

4.  [Scientific fraud. When researchers become forgers].

Authors:  L Eberhart
Journal:  Anaesthesist       Date:  2009-12       Impact factor: 1.041

Review 5.  [What can we learn from the Scott Reuben case? Scientific misconduct in anaesthesiology].

Authors:  H L Rittner; P Kranke; M Schäfer; N Roewer; A Brack
Journal:  Anaesthesist       Date:  2009-12       Impact factor: 1.041

6.  Reporting of article retractions in bibliographic databases and online journals.

Authors:  Kath Wright; Catriona McDaid
Journal:  J Med Libr Assoc       Date:  2011-04

7.  Pain from donor site after anterior cervical fusion with bone graft: a prospective randomized study with 12 months of follow-up.

Authors:  M Skeppholm; C Olerud
Journal:  Eur Spine J       Date:  2012-08-14       Impact factor: 3.134

Review 8.  Perioperative pain management.

Authors:  Srinivas Pyati; Tong J Gan
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

9.  Iliac crest reconstruction to reduce donor-site morbidity: technical note.

Authors:  Joseph Richard Dusseldorp; Ralph J Mobbs
Journal:  Eur Spine J       Date:  2009-08-04       Impact factor: 3.134

10.  [Comparison of the peripheral and central effects of opiates after iliac crest transplants. Reconstruction of severely atrophied maxilla].

Authors:  A S Virnik; A Gaggl; R Likar; H Stettner; F M Chiari
Journal:  Schmerz       Date:  2009-06       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.